ANTI-CD19 CAR-T CELLS OVEREXPRESSING THE PROTEIN PHF19 HAVE ALTERED MEMORY AND EXHAUSTION PHENOTYPES

Vol 3, 2022 - 155121
ES - Especialização/Aperfeiçoamento
Favorite this paper
How to cite this paper?
Abstract

ANTI-CD19 CAR-T CELLS OVEREXPRESSING THE PROTEIN PHF19 HAVE ALTERED MEMORY AND EXHAUSTION PHENOTYPES

Hajdu, Karina L.1, Ribeiro, Leonardo1, Abdo, Luiza M.1, Aragão, Emmanuel A.1, Bonamino, Martin H.1,2
1Molecular Carcinogenesis Program, Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ; 2Vice - Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil

INTRODUCTION AND OBJECTIVES: CAR T cells are genetically modified to express a synthetic receptor that recognizes surface antigens. CAR-T therapy cost is largely impacted by using clinical-grade viral vectors. Transposon-based systems are more economic than viral vectors, being a good strategy for cost reduction. Another limitation is short-term persistence of T-cells in vivo, often restricted by acquisition of an exhausted phenotype. Recent work showed that Phf19, a member of the PRC2 complex, can induce formation of memory cells and avoid terminal differentiation of CD8+ lymphocytes. To address the phenotype and function of anti-CD19 CAR-T cells overexpressing Phf19 generated with transposon systems Sleeping Beauty (SB) and piggyBac (PB). MATERIAL AND METHODS: To generate CAR-T cells, we electroporated peripheral blood mononuclear cells from healthy donors with the SB or PB transposases along with the respective transposon plasmid. Cells were activated with anti-CD3/CD28 beads and expanded for 8 to 12 days. T cell phenotype was assessed by flow cytometry, and we evaluated lysis capacity through Calcein-AM assay. RESULTS AND CONCLUSION: Our results show that the PB system is more effective in providing CAR expression with the present construct containing Phf19 when compared to the SB system. We were able to obtain around 2 million CAR+ cells per well with transfection rates ranging between 20-30% 24h post-electroporation and about 10-15% on day 12 of expansion. We did not observe significant differences in lytic capacity with Phf19 overexpression in a co-culture with CD19+ leukemia cell line Nalm-6. Regarding T cell phenotype, Phf19 overexpression led to increased formation of central memory-like T cells marked by increased expression of CCR7, and a reduction of effector memory-like cells. Interestingly, we also observed increased levels of the inhibitory receptor PD-1 in Phf19+ CAR-T cells, particularly within the CD4+ compartment. These results suggest an ambiguous role for Phf19 in T lymphocytes that may differ between CD8+ and CD4+ cells and paves the way for assessment of the effector function of these cells in vivo. Particularly, we believe Phf19 indirectly upregulated both CCR7 and PD-1, which we intend to further explore.

Keywords: CAR-T cells, Immunotherapy, Exhaustion, Transposon systems, Gene therapy
Supported by: FAPERJ and CNPq

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Instituto Nacional de Câncer (INCA)
  • 2 Instituto Nacional do Câncer (INCA)
  • 3 INSTITUTO NACIONAL DE CÂNCER (INCA)
  • 4 Instituto Nacional de Câncer José Alencar Gomes da Silva
  • 5 INSTITUTO NACIONAL DO CANCER
Track
  • 2. Cellular Biology
Keywords
CAR-T cells
Immunotherapy
Exhaustion
Transposon systems
gene therapy